NCI takes lead on serological test validation as cancer center joins COVID-19 fight
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Deploying its HPV serology testing lab to validate COVID-19 assays is one of three ways NIH’s National Cancer Institute is retooling cancer research activities to take on the pandemic.
In a virtual advisory committee meeting Thursday, Deputy Director Douglas Lowy shared how NCI’s Frederick National Laboratory for Cancer Research will help validate COVID-19 serology tests, discover